PDF(Pubmed)
Abstract：
Exposure of pregnant women and newborns to secondhand smoke (SHS) can lead to adverse maternal and neonatal health outcomes. Among expectant and new fathers, who are the main source of SHS exposure for pregnant women, new mothers and babies, smoking rates remain high. A partner\'s pregnancy potentially constitutes a critical period where expectant and new fathers are motivated to quit smoking. However, there is no consensus on the optimal form and delivery of smoking cessation and relapse-prevention interventions. We present a systematic review and network meta-analysis protocol that aims to synthesise and evaluate the effectiveness of smoking cessation and relapse-prevention interventions tailored for this population.
To identify relevant studies, we will conduct a comprehensive search, in English and Chinese, of 10 electronic databases. The review will include randomised and quasi-randomised controlled trials that compare behavioural interventions (tailored and non-tailored) with/without the addition of pharmacotherapy with usual care, a minimal or placebo control for assisting expectant and new fathers to quit smoking and prevent smoking relapse. The primary outcome of interest is the self-reported and/or biochemically verified smoking abstinence at ≥1-month follow-up. Two reviewers will independently screen, select and extract relevant studies, and perform a quality assessment. Disagreements will be resolved by a consensus or third-party adjudication. The Cochrane Risk of Bias tool V.2 will be used to assess the risk of bias in the included studies. We will obtain the results of the systematic review through pooled quantitative analyses using a network meta-analysis. Sensitivity and subgroup analyses will be performed.
Ethical approval is not required for this systematic review of published data. The findings will be disseminated via peer-reviewed publication.
CRD42022340617.
To identify relevant studies, we will conduct a comprehensive search, in English and Chinese, of 10 electronic databases. The review will include randomised and quasi-randomised controlled trials that compare behavioural interventions (tailored and non-tailored) with/without the addition of pharmacotherapy with usual care, a minimal or placebo control for assisting expectant and new fathers to quit smoking and prevent smoking relapse. The primary outcome of interest is the self-reported and/or biochemically verified smoking abstinence at ≥1-month follow-up. Two reviewers will independently screen, select and extract relevant studies, and perform a quality assessment. Disagreements will be resolved by a consensus or third-party adjudication. The Cochrane Risk of Bias tool V.2 will be used to assess the risk of bias in the included studies. We will obtain the results of the systematic review through pooled quantitative analyses using a network meta-analysis. Sensitivity and subgroup analyses will be performed.
Ethical approval is not required for this systematic review of published data. The findings will be disseminated via peer-reviewed publication.
CRD42022340617.
摘要：
背景：孕妇和新生儿暴露于二手烟（SHS）会导致不良的母婴健康结局。在准爸爸和新爸爸中，她们是孕妇接触SHS的主要来源，新的母亲和婴儿，吸烟率仍然很高。伴侣的怀孕可能构成了一个关键时期，准爸爸和新爸爸都有戒烟的动机。然而,对于戒烟和预防复发干预措施的最佳形式和实施尚无共识.我们提出了一个系统评价和网络荟萃分析方案，旨在综合和评估针对该人群的戒烟和预防复发干预措施的有效性。
方法：为了确定相关研究，我们将进行全面搜索，英语和汉语，10个电子数据库。审查将包括随机和准随机对照试验，比较行为干预（量身定制和非量身定制），有/没有增加药物治疗和常规护理。最小或安慰剂对照，用于帮助准父亲和新父亲戒烟并防止吸烟复发。感兴趣的主要结果是在≥1个月的随访中自我报告和/或生化验证的戒烟。两名审阅者将独立筛选，选择并提取相关研究，并进行质量评估。分歧将通过协商一致或第三方裁决解决。Cochrane偏差风险工具V.2将用于评估纳入研究的偏差风险。我们将使用网络荟萃分析通过汇总定量分析获得系统综述的结果。将进行敏感性和亚组分析。
背景：对已发表数据的系统评价不需要伦理批准。调查结果将通过同行评审的出版物传播。
■CRD4202234617。
方法：为了确定相关研究，我们将进行全面搜索，英语和汉语，10个电子数据库。审查将包括随机和准随机对照试验，比较行为干预（量身定制和非量身定制），有/没有增加药物治疗和常规护理。最小或安慰剂对照，用于帮助准父亲和新父亲戒烟并防止吸烟复发。感兴趣的主要结果是在≥1个月的随访中自我报告和/或生化验证的戒烟。两名审阅者将独立筛选，选择并提取相关研究，并进行质量评估。分歧将通过协商一致或第三方裁决解决。Cochrane偏差风险工具V.2将用于评估纳入研究的偏差风险。我们将使用网络荟萃分析通过汇总定量分析获得系统综述的结果。将进行敏感性和亚组分析。
背景：对已发表数据的系统评价不需要伦理批准。调查结果将通过同行评审的出版物传播。
■CRD4202234617。
